Page: Reflection paper on a tailored clinical approach in biosimilar development-2026/3/27

关于将TL118颗粒纳入“儿童抗肿瘤药物研发鼓励试点计划（星光计划）”试点项目的公示-2026/5/8

Pre-authorisation guidance-2023/4/25

Final Guidance: Policy for Testing of Alcohol (Ethanol) and Isopropyl Alcohol for Methanol-2023/10/13

Document: Policy 44: European Medicines Agency policy on the handling of competing interests of scientific committees’ members and experts - As adopted by EMA Management Board on 11-12 December 2024-2025/1/14

Page: Type-II variations: questions and answers-2025/2/18

Document: European shortages monitoring platform (ESMP) API - Instructions to request access for national competent authorities (NCAs) and marketing authorisation holders (MAHs)-2025/3/27

Page: Data protection and privacy at EMA-2025/5/2

Document: CTIS newsflash - 10 June 2025-2025/6/12

Document: Timetable: Annual renewal application of conditional marketing authorisation - ATMP-2025/7/17